期刊文献+

ADAM-33相关miR在支气管哮喘小鼠中的表达 被引量:3

Expression of ADAM-33-related miRNA in a murine asthma model
下载PDF
导出
摘要 目的观察与ADAM-33相关的microRNA(miR)在卵清蛋白(ovalbumin,OVA)诱导的支气管哮喘小鼠模型中的表达。方法制备OVA诱导的支气管哮喘小鼠模型,检测支气管肺泡灌洗液(bronchoalveolar lavage fluid,BALF)中细胞数及建立组织病理验证模型。应用RT-PCR法检测支气管哮喘小鼠模型肺组织中ADAM-33 mRNA的表达差异。应用RT-PCR法检测支气管哮喘小鼠模型肺组织miR-140-5p、miR-148a、miR-138-1、miR-27b与对照组的表达差异。结果 OVA诱导的支气管哮喘小鼠模型组BALF中细胞总数及嗜酸性粒细胞数明显高于正常对照组。组织病理显示支气管哮喘模型组炎症细胞浸润明显高于正常对照组。ADAM-33 mRNA在OVA诱导的支气管哮喘小鼠模型肺组织中高表达。在支气管哮喘组,miR-140-5p的表达约为正常对照组的0.12倍;miR-148a的表达约为正常对照组的0.28倍;miR-138-1的表达约为正常对照组的0.35倍;miR-27b的表达约为正常对照组的0.22倍。结论 ADAM-33在OVA诱导的支气管哮喘小鼠模型中明显上调,相关的miR-140-5p、miR-148a、miR-138-1、miR-27b在OVA诱导的支气管哮喘小鼠模型中明显下调。 Purpose To investigate the expression of ADAM-33-related miRNA in a murine asthma model. Methods The number of cells in the bronchoalveolar lavage fluid (BALF) of OVA-induced murine asthma model was assessed. Expression of miRNA in the model was analyzed by realfime-PCR. Results The cell number was significantly higher in BALF from the murine asthma model than that from control. Enhanced eosinophilic infiltration in lung was observed in the murine asthma model. ADAM-33 mRNA was upregu- lated in the murinc asthma model. Compared to the control, miH-ld0-5p (about O. 12 fold) , miR-148a (about O. 28 fold), miR-138- l (about 0. 35 fold), and miR-27b (about 0. 22 fold) were downregulated. Conclusions ADAM-33 is significantly upregulated in the OVA-induced murine asthma model. Meanwhile, the down-regulation of ADAM-33-related miRNAs (miR-140-5p, miR-148a, miR-138-1 and miR-27b) is also observed in this model.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第12期1368-1371,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 南京市医学科技发展项目(QYK09163/201108012)
关键词 支气管哮喘 ADAM-33 MICRORNA 小鼠 bronchial asthma ADAM-33 microRNA mice
  • 相关文献

参考文献12

  • 1全国儿科哮喘协作组.2000年与1990年儿童支气管哮喘患病率的调查比较[J].中华结核和呼吸杂志,2004,27(2):112-116. 被引量:248
  • 2Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA dissemination committee report [J]. Allergy, 2004,59(5) :469 -78.
  • 3Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004,116(2) :281 -97.
  • 4Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/mi- croRNA-155 for normal immune function[ J]. Science, 2007,316 (5824) :608 - 11.
  • 5章建国,张弘,李峰,黄华,施公胜.涎腺腺样囊性癌中ADAM-17的表达及临床意义[J].临床与实验病理学杂志,2012,28(5):514-517. 被引量:4
  • 6Awasthi S, Tripathi P, Ganesh S, et al. Association of ADAM33 gene polymorphisms with asthma in Indian children [ J ]. J Hum Genet, 2011,56(3) :188 -95.
  • 7Holgate S T. ADAM metallopeptidase domain 33 ( ADAM33 ) : i-dentification and role in airways disease[ J ]. Drug News Perspect, 2010,23(6) :381 -7.
  • 8Van Rooij E, Purcell A L, Levin A A. Developing MicroRNA therapeutics [ J ]. Circ Res, 2012,110 ( 3 ) :496 - 507.
  • 9Chiba Y, Misawa M. MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hy- perresponsiveness in asthma [ J ]. J Pharmacol Sci, 2010,114 ( 3 ) : 264 - 8.
  • 10Mohamed J S, Lopez M A, Boriek A M. Mechanical stretch up- regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta [ J ]. J Biol Chem, 2010,285 (38) :29336 -47.

二级参考文献12

  • 1儿童哮喘诊断标准和治疗常规[J].中华儿童保健杂志,1993,1(4):249-251. 被引量:325
  • 2陈国璋,刘晓红,周晓军.涎腺肿瘤的病理诊断[J].临床与实验病理学杂志,2007,23(1):1-5. 被引量:34
  • 3全国儿科哮喘协作组.全国90万0-14岁儿童中支气管哮喘患病情况调查[J].中华结核和呼吸杂志,1993,16:64-68.
  • 4Suganuma M,Okabe S,Marino M W,et al.Essential role of tumour necrosis factor alpha (TNF-alpha) in tumour promotion as revealed by TNF-alpha deficient mice[J].Cancer Res,1999,59(18):4516-8.
  • 5McGowan P M,Ryan B M,Hill A D,et al.Ryan ADAM-17 Expression in breast cancer correlates with variables of tumor progression[J].Clin Cancer Res,2007,13(8)2335-43.
  • 6Zhou B B,Fridman J S,Liu X,et al.ADAM proteases,ErbB pathways and cancer[J].Expertop in Investig Drugs,2005,14(6):591.
  • 7Ringel J,Jesnowski R,Moniaux N,et al.Aberrant expression of a disintegrin and metalloproteinase17/tumor necrosis factor-a converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma[J].Cancer Res,2006,66(18):9045-53.
  • 8Yamada D,Ohuchida K,Mizumoto K,et al.Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer[J].Anticancer Res,2007,27(2):793.
  • 9Yoshimura T,Tomita T,Dixon M F,et al.ADAMs (a disintegrin and metallop roteinase) messenger RNA expression in helicobacter pylori-infected,normal,and neoplastic gastric mucosa[J].J Infect Dis,2002,185(3):332-40.
  • 10Takamune Y,lkebe T,Nagano O,et al.Involvement of NF2-kappaB2 mediated maturation of ADAM217 in the invasion of oral squamouscell carcinoma[J].Biochem Biophys Res Commun,2008,365(2):393.

共引文献250

同被引文献26

引证文献3

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部